J A Black, D N Challacombe, B G Ockenden. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Edema/drug therapyEscherichia coli/isolation & purificationFemaleFluorescent Antibody TechniqueGlomerulonephritis/pathologyHumansHydrocephalus/surgeryHydrochlorothiazide/therapeutic useNephrotic Syndrome/etiologyPostoperative ComplicationsSepsis/etiologySpironolactone/therapeutic useStaphylococcal Infections
Substances: See more » HydrochlorothiazideSpironolactone
Year: 1965 PMID: 4165274 DOI: 10.1016/s0140-6736(65)92901-6
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321